Adverse effects of rabies pre- and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients

Infection

Volumn 35, Issue 4, 2007, Pages 219-224

  Mattner, F ^a,b   Bitz, F ^c   Goedecke, M ^d   Viertel, A ^e   Kuhn, S ^b   Gastmeier, P ^b   Mattner, L ^f   Biertz, F ^b   Heim, A ^b   Henke Gendo, C ^b   Engelmann, I ^b   Martens, A ^b   Struber M ^b   Schulz, T F ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Clinic for Nephrology (Nephrologisches Zentrum Niedersachsen)   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ARTHRALGIA; ARTICLE; BRAIN DISEASE; CHILL; DIARRHEA; DIZZINESS; DRUG WITHDRAWAL; ERYTHEMA; FATIGUE; FEVER; GRAFT RECIPIENT; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; INJECTION PAIN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALAISE; MYALGIA; NAUSEA; OCCUPATIONAL EXPOSURE; ORGAN DONOR; PARESTHESIA; RABIES; RASH; SWELLING; VACCINATION; VOMITING;

CONTACT TRACING; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FOLLOW-UP STUDIES; GERMANY; HEALTH PERSONNEL; HUMANS; IMMUNIZATION, PASSIVE; MASS IMMUNIZATION; OCCUPATIONAL EXPOSURE; PROSPECTIVE STUDIES; RABIES; RABIES VACCINES; TRANSPLANTS; VACCINATION;

EID: 34547666897     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6277-7     Document Type: Article

References (21)

1. Patient received cornea: rabies case linked to transplant. Am Med News 1978; 21: 3.
2. Houff SA, Burton RC, Wilson RW, et al. Human-to-human transmission of rabies virus by corneal transplant. N Engl J Med 1979; 300: 603-604.
3. Sureau P, Portnoi D, Rollin P, Lapresle C, Chaouni-Berbich A: Prevention of inter-human rabies transmission after corneal graft. C R Seances Acad Sci III 1981; 293: 689-692.
4. Anonymous: Investigation of rabies infections in organ donor and transplant recipients - Alabama, Arkansas, Oklahoma, and Texas, 2004. MMWR Morb Mortal Wkly Rep 2004; 53: 586-589.
5. Jackson AC: Transmission of rabies from an organ donor. N Engl J Med 2005; 352: 2551-2; author reply 2552.
6. Jenwitheesuk E: Transmission of rabies from an organ donor. N Engl J Med 2005; 352: 2551; author reply 2552.
7. Lapierre V, Tiberghien P: Transmission of rabies from an organ donor. N Engl J Med 2005; 352: 2552; author reply 2552.
8. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352: 1103-1111.
9. Informationen zu den Tollwutübertragungen durch Spenderorgane. Epidemiol Bull 2005: 70.
10. Mattner F, Henke-Gendo C, Martens A, et al. Risk of rabies infection and adverse effects of postexposure prophylaxis in healthcare workers and other patient contacts exposed to a rabies virus-infected lung transplant recipient. Infect Control Hosp Epidemiol 2007; 28: 513-518.
11. Thraenhart O, Ramakrishnan K: Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera. J Biol Stand 1989; 17: 291-309.
12. Thraenhart O, Kreuzfelder E, Hillebrandt M, et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin Immunol Immunopathol 1994; 71: 287-292.
13. Abu Sin M, Matzdorf P, Heitlinger A, Mattner F, Geiss HK, Maslo D, Beyrer K, Ammon A: Assessment of immunisation after rabies infection in organ transplant recipients (vol 10). EPIET Scientific Seminar, October 2005.
14. Anonymous: Rabies vaccines. Wkly Epidemiol Rec 2002; 77: 109-119.
15. Dreesen DW, Fishbein DB, Kemp DT, Brown J: Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 1989; 7: 397-400.
16. Lumbiganon P, Chaiprasithikul P, Sookpranee T, Paholpak S, Wasi C: Pre-exposure vaccination with purified chick embryo cell rabies vaccines in children. Asian Pac J Allergy Immunol 1989; 7: 99-101.
17. Sehgal S, Bhattacharya D, Bhardwaj M: Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population. J Commun Dis 1995; 27: 36-43.
18. Chutivongse S, Wilde H, Benjavongkulchai M, Chomchey P, Punthawong S: Postexposure rabies vaccination during pregnancy: effect on 202 women and their infants. Clin Infect Dis 1995; 20: 818-820.
19. Fishbein DB, Dreesen DW, Holmes DF, et al. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations. Vaccine 1989; 7: 437-442.
20. Arora A, Moeller L, Froeschle J: Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine. J Travel Med 2004; 11: 195-199.
21. Jaiiaroensup W, Lang J, Thipkong P, et al. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally: results of a prospective randomized trial. Vaccine 1998; 16: 1559-1562.